Introduction. The role of Pulmonary and Activation-Regulated Chemokine (PARC) in the physiopathology of Chronic Obstructive Pulmonary Disease (COPD) is not fully understood. The aim of the present study is to analyze the expression of PARC in lung tissue and its relationship with the vascular remodeling of the systemic and pulmonary arteries of COPD subjects. Methods. To achieve this objective, protein and gene expression experiments, together with ELISA assays, were performed on the lung tissue, intercostal arteries and serum samples from COPD patients, non-obstructed smokers (NOS) and never-smokers (NS). Results. A total of 57 subjects were included in the analysis (23 COPD, 18 NOS and 16 NS). In the comparisons between groups, ...
RATIONALE: There are no accepted blood-based biomarkers in chronic obstructive pulmonary disease (CO...
Background: Previous studies have shown that the arterial wall is a potential source of inflammatory...
RATIONALE: There are no accepted blood-based biomarkers in chronic obstructive pulmonary disease (CO...
Introduction. The role of Pulmonary and Activation-Regulated Chemokine (PARC) in the physiopathology...
Introduction. The role of Pulmonary and Activation-Regulated Chemokine (PARC) in the physiopathology...
Introduction. The role of Pulmonary and Activation-Regulated Chemokine (PARC) in the physiopathology...
Introduction. The role of Pulmonary and Activation-Regulated Chemokine (PARC) in the physiopathology...
Introduction. The role of Pulmonary and Activation-Regulated Chemokine (PARC) in the physiopathology...
Introduction: The role of Pulmonary and Activation-Regulated Chemokine (PARC) in the physiopathology...
The role of Pulmonary and Activation-Regulated Chemokine (PARC) in the physiopathology of Chronic Ob...
Introduction: The role of Pulmonary and Activation-Regulated Chemokine (PARC) in the physiopathology...
Raw data from Vascular Disease in COPD: Systemic and Pulmonary expression of PARC (Pulmonary and Act...
RATIONALE: There are no accepted blood-based biomarkers in chronic obstructive pulmonary disease (CO...
RATIONALE: There are no accepted blood-based biomarkers in chronic obstructive pulmonary disease (CO...
RATIONALE: There are no accepted blood-based biomarkers in chronic obstructive pulmonary disease (CO...
RATIONALE: There are no accepted blood-based biomarkers in chronic obstructive pulmonary disease (CO...
Background: Previous studies have shown that the arterial wall is a potential source of inflammatory...
RATIONALE: There are no accepted blood-based biomarkers in chronic obstructive pulmonary disease (CO...
Introduction. The role of Pulmonary and Activation-Regulated Chemokine (PARC) in the physiopathology...
Introduction. The role of Pulmonary and Activation-Regulated Chemokine (PARC) in the physiopathology...
Introduction. The role of Pulmonary and Activation-Regulated Chemokine (PARC) in the physiopathology...
Introduction. The role of Pulmonary and Activation-Regulated Chemokine (PARC) in the physiopathology...
Introduction. The role of Pulmonary and Activation-Regulated Chemokine (PARC) in the physiopathology...
Introduction: The role of Pulmonary and Activation-Regulated Chemokine (PARC) in the physiopathology...
The role of Pulmonary and Activation-Regulated Chemokine (PARC) in the physiopathology of Chronic Ob...
Introduction: The role of Pulmonary and Activation-Regulated Chemokine (PARC) in the physiopathology...
Raw data from Vascular Disease in COPD: Systemic and Pulmonary expression of PARC (Pulmonary and Act...
RATIONALE: There are no accepted blood-based biomarkers in chronic obstructive pulmonary disease (CO...
RATIONALE: There are no accepted blood-based biomarkers in chronic obstructive pulmonary disease (CO...
RATIONALE: There are no accepted blood-based biomarkers in chronic obstructive pulmonary disease (CO...
RATIONALE: There are no accepted blood-based biomarkers in chronic obstructive pulmonary disease (CO...
Background: Previous studies have shown that the arterial wall is a potential source of inflammatory...
RATIONALE: There are no accepted blood-based biomarkers in chronic obstructive pulmonary disease (CO...